Literature DB >> 3774962

The natural history of membranous nephropathy in the West of Scotland.

R MacTier, J M Boulton Jones, C D Payton, A McLay.   

Abstract

Membranous nephropathy was diagnosed in 54 patients between January 1975 and June 1983 in the Royal Infirmary, Glasgow. It was the commonest cause of the nephrotic syndrome and, with IgA nephropathy, the commonest primary glomerular disease. A cause was found in 10 patients. The last seven patients diagnosed were enrolled in the MRC trial. The natural history of the remaining 37 patients with idiopathic membranous nephropathy was studied. After an average observation period of 64 months, 50 per cent had stable renal function with or without proteinuria and 50 per cent had progressive renal failure or had died of other causes (five patients). Of the factors examined only heavy proteinuria and hypertension were significantly more common in patients who developed progressive renal failure. No patient who entered remission relapsed. Vascular complications were an important cause of morbidity and mortality. Incidence of events of arterial occlusion was significantly higher in these patients compared with patients with IgA nephropathy. Treatment of patients with membranous nephropathy should, therefore, be judged not only by its efficacy in preventing progressive renal failure, but also by its effect on vascular disease and by its toxicity.

Entities:  

Mesh:

Year:  1986        PMID: 3774962

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  11 in total

1.  Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.

Authors:  L R Baker; B Tucker; I C Macdougall; R Oommen
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

Review 2.  Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management.

Authors:  Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 3.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

4.  Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.

Authors:  Natalia Polanco; Elena Gutiérrez; Adelardo Covarsí; Francisco Ariza; Agustín Carreño; Ana Vigil; José Baltar; Gema Fernández-Fresnedo; Carmen Martín; Salvador Pons; Dolores Lorenzo; Carmen Bernis; Pilar Arrizabalaga; Gema Fernández-Juárez; Vicente Barrio; Milagros Sierra; Ines Castellanos; Mario Espinosa; Francisco Rivera; Aniana Oliet; Francisco Fernández-Vega; Manuel Praga
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

5.  The natural history of the non-nephrotic membranous nephropathy patient.

Authors:  Michelle A Hladunewich; Stephan Troyanov; Jennifer Calafati; Daniel C Cattran
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-06       Impact factor: 8.237

6.  Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.

Authors:  Aliza Thompson; Daniel C Cattran; Melanie Blank; Patrick H Nachman
Journal:  J Am Soc Nephrol       Date:  2015-06-15       Impact factor: 10.121

7.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

8.  Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis.

Authors:  T Tóth; S Takebayashi
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

9.  A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.

Authors:  Michelle A Hladunewich; Daniel Cattran; Laurence H Beck; Ayodele Odutayo; Sanjeev Sethi; Rivka Ayalon; Nelson Leung; Heather Reich; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2014-04-08       Impact factor: 5.992

Review 10.  Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.

Authors:  Agnieszka Pozdzik; Isabelle Brochériou; Cristina David; Fahd Touzani; Jean Michel Goujon; Karl Martin Wissing
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.